Ceftin (cefuroxime axetil)

Company
GlaxoSmithKline

Approval Status
Approved September 1997

Treatment for
acute bronchitis

Areas
Respiratory

Ceftin (Cefuroxime axetil) has been approved by the U.S. Food and Drug Administration for the treatment of secondary bacterial infections of acute bronchitis with 5-day therapy.

Ceftin (cefuroxime axetil) Drug Information

The Ceftin (cefuroxime axetil) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top